BETAAccess all features while we're in beta! Some features may become paid later.Got feedback? Reach us 👉

Loading MAZE charts…

Search ticker or company⌘K

MAZE

01Multicharts 02Comparables 03Price target

May we use analytics cookies to see how vpside is used, including anonymous session recordings? Accepting also loads the price chart, which sets its own cookies. Essential cookies are always on. Privacy

Loading MAZE price target model…

Search ticker or company⌘K

MAZE

01Multicharts 02Comparables 03Price target

MAZE price target model · vpside

⌘K

MAZEMarket cap $1.9B/Last filing 10-Q, Q2 FY26 · 11 Aug 2026/MAZEMarket cap $1.9B/Last filing 10-Q, Q2 FY26 · 11 Aug 2026/MAZEMarket cap $1.9B/Last filing 10-Q, Q2 FY26 · 11 Aug 2026/MAZEMarket cap $1.9B/Last filing 10-Q, Q2 FY26 · 11 Aug 2026/

Filings synced 13:22 · Prices: prior close 30 Oct

MAZE

Maze Therapeutics, Inc.

Nasdaq · Biological products, (no diagnostic substances) (SIC 2836) · FY ends 31 Dec

01Multicharts 02Comparables 03Price target

There isn’t enough filed history to build a price target for this company yet.